BBUC vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BBUC exhibits extremely weak financial health with a Piotroski F-Score of just 1/9, indicating significant deterioration in fundamental performance. The negative Price/Book ratio of -5.05 and uncalculable Altman Z-Score suggest severe balance sheet distress, likely due to negative equity. Despite a recent 1-year price return of +52.8%, this is disconnected from fundamentals, as the company reports a -13.93% profit margin, 3.52 Debt/Equity ratio, and -23.90% YoY revenue growth. Valuation metrics are largely unavailable, but the stock appears deeply impaired from a financial stability and profitability standpoint.
JPM shows bullish fundamentals based on deterministic rules. Financial strength is weak (F-Score 2/9). Key strengths include strong valuation and growth metrics. Price trades at a 109.8% premium to fair value estimate ($140.21), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
BBUC vs JPM: Head-to-Head Comparison
This page compares Brookfield Business Corporation (BBUC) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.